Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Kypha logo — Precision Immune Monitoring Delivered

Kypha

Precision Immune Monitoring Delivered

Founded 2009 United States United States 15 employees Venture round Total: $24.01M Biotechnology, Health Care +1

General Information

Company Name Kypha
Founded Year 2009
Location United States United States
Employees 15
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Venture round
Business Model B2B, D2C, SaaS
Revenue Model Service Fee, Usage Based, Product Sales
Social

BounceWatch is an independent company data service, not affiliated with Kypha. To contact Kypha, visit kypha.net.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Kypha compare?

A PDF of Kypha and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Kypha soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Kypha

Kypha, founded in 2009, operates at the forefront of precision biotechnology, focusing on immune system insights. Headquartered in the United States, this company has carved a niche within the Biotechnology, Health Care, and Medical Devices industries.

With the slogan "Precision Immune Monitoring Delivered," Kypha specializes in real-time analysis of immune signals, specifically targeting complement proteins, cytokines, and chemokines. Their CompAct® and RapiPlex platforms provide rapid, point-of-care assessments that dramatically enhance the precision of immune status evaluations, guiding more informed clinical and therapeutic decisions.

Their most recent financial leap was marked by a $5.15M venture round investment in May 2022, underscoring investor confidence. Kypha's innovative approach positions it as a promising partner for those looking to drive advancements in real-time immune monitoring and therapeutic developments.

Business keywords: Precision Medicine, Immune Monitoring, Complement System, Point-of-Care Diagnostics, Autoimmune Disorders, Inflammatory Disorders, Real-Time Diagnostics, Cytokine Analysis, Chemokine Analysis, Immune Status Assessment, Diagnostic Technology, Clinical Intervention, FDA Clearance, Life Sciences Innovation, Therapeutic Decision Making

Services & Products

assay development and manufacturing
custom panel development
exploratory biomarker analysis
current biomarker detection

Target Customers

therapeutic developers clinical healthcare providers biotech companies immunology researchers

Funding Rounds & Investors (15)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $5.15M -
12 May 2022
Series A $4.00M 1
Arsenal Capital Management
Arsenal Capital Management
20 Dec 2018
Venture Round $950.00K -
20 Jul 2018
Venture Round $5.46M 2
BioGenerator Arsenal Capital Management
BioGenerator, Arsenal Capital Management
07 May 2018
Venture Round Undisclosed 1
Serra Ventures
Serra Ventures
20 Oct 2017
Venture Round Undisclosed 1
Serra Ventures
Serra Ventures
06 Jan 2017
Venture Round Undisclosed 1
Serra Ventures
Serra Ventures
02 May 2016
Debt Financing $2.10M 1
Serra Ventures
Serra Ventures
24 Nov 2015
Convertible Note Undisclosed 1
Serra Ventures
Serra Ventures
04 Aug 2015
Venture Round $3.50M 3
Serra Ventures BioGenerator Arsenal Capital Management
Serra Ventures, BioGenerator +1
21 Nov 2014

View All 15 Funding Rounds

Kypha Alternatives & Competitors

View All Alternatives
Kypha vs
Immunaeon
Immunaeon United States

Connecting Today's Science to Tomorrow's Cures

5 employees
Biopharma, Biotechnology
Kypha vs
Immunexpress Inc.
Immunexpress Inc. United States

We are pioneering the technology that analyzes the immune system to rapidly detect sepsis.

Venture round
20 employees
Biotechnology, Health Care
Kypha vs
Tempus AI
Tempus AI United States

Tempus AI, Inc. (NASDAQ: TEM) is a technology company leading the adoption of AI to advance precisio...

Post-IPO Debt
3178 employees
AI, Biotechnology
View all alternatives

FAQ About Kypha

Precision Immune Monitoring Delivered
Kypha was founded in 2009.
Kypha is headquartered in United States.
Kypha operates in Biotechnology, Health Care and Medical Devices. Its work centres on Precision Medicine, Immune Monitoring, Complement System and Point-of-Care Diagnostics. Its customers include therapeutic developers, clinical healthcare providers and biotech companies.
Kypha has a B2B, D2C and SaaS business model. Its revenue comes from Service Fee, Usage Based and Product Sales.
Kypha has approximately 15 employees.
Kypha has completed 15 funding rounds, raising a total of $24.01M. The latest funding stage is Venture round.
Kypha offers: assay development and manufacturing, custom panel development, exploratory biomarker analysis, current biomarker detection.
Top alternatives and competitors to Kypha include Immunaeon, Immunexpress Inc., Tempus AI, anvajo, GILUPI GmbH. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Kypha and Immunaeon are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Kypha, https://bouncewatch.com/company/kypha, updated 26 March 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes